首页> 外文期刊>Medical Devices: Evidence and Research >In Quest of Pathognomonic/Endophenotypic Markers of Attention Deficit Hyperactivity Disorder (ADHD): Potential of EEG-Based Frequency Analysis and ERPs to Better Detect, Prevent and Manage ADHD
【24h】

In Quest of Pathognomonic/Endophenotypic Markers of Attention Deficit Hyperactivity Disorder (ADHD): Potential of EEG-Based Frequency Analysis and ERPs to Better Detect, Prevent and Manage ADHD

机译:在追求病症缺陷多动障碍(ADHD)的情况下:基于EEG的频率分析和ERP的潜力,以更好地检测,预防和管理ADHD

获取原文
           

摘要

Attention deficit hyperactivity disorder (ADHD) is a chronic heritable developmental delay psychiatric disorder requiring chronic management, characterized by inattention, hyperactivity, hyperkinectivity and impulsivity. Subjective clinical evaluation still remains crucial in its diagnosis. Discussed are two key aspects in the “characterizing ADHD” and on the quest for objective “pathognomonic/endophenotypic diagnostic markers of ADHD”. The first aspect briefly revolves around issues related to identification of pathognomonic/endophenotypic diagnostic markers in ADHD. Issues discussed include changes in ADHD definition, remission/persistence and overlapping-symptoms cum shared-heritability with its co-morbid cross-border mental disorders. The second aspect discussed is neurobiological and EEG-based studies on ADHD. Given the neurobiological and temporal aspects of ADHD symptoms the electroencephalograph (EEG) like NeuralScan by Medeia appears as an appropriate tool. The EEGs appropriateness is further enhanced when coupled with suitable behavior/cognitive/motor/psychological tasks/paradigms yielding EEG-based markers like event-related-potential (ERPs like P3 amplitudes and latency), reaction time variability (RTV), Theta:Beta ratio (TBR) and sensorimotor rhythm (SMR). At present, these markers could potentially help in the neurobiological characterization of ADHD and either help in identifying or lay the groundwork for identifying pathognomonic and/or endophenotypic EEG-based markers enabling its diagnosis, treatment and management.
机译:注意力缺陷多动障碍(ADHD)是一种需要慢性管理的慢性遗传发育延迟精神疾病,其特征是疏忽,多动,高度和冲动。主观临床评估在其诊断中仍然至关重要。讨论是“表征ADHD”的两个关键方面,并追求目标“adhd的客观”病例/内卵型诊断标志物“。第一方面短暂围绕与ADHD中的病例/内卵型诊断标志物鉴定有关的问题。所讨论的问题包括ADHD定义,缓解/持续性和重叠症状的变化与其共同的跨境精神障碍共享遗传性。讨论的第二方面是对ADHD的神经生物学和基于脑电图的研究。鉴于ADHD症状的神经生物学和时间方面症状,Medeia的神经球膜(EEG)如神经核苷酸呈现为适当的工具。当与合适的行为/认知/电动机/心理任务/范式相结合时,进一步增强了eEGs适当性,从而产生了基于EEG的标记,如事件相关的潜力(如P3众巨大和潜伏期),反应时间变异性(RTV),THETA:BETA比率(TBR)和SensorImotor节奏(SMR)。目前,这些标记可能有助于ADHD的神经生物学表征,并且有助于识别或奠定基于基于诊断,治疗和管理的基于诊断,治疗和管理的基于基于诊断的基于诊断的基于基于植物的基于基于脑电图的基于基于基于脑电图的标记的基于诊断,治疗和管理的基于基于诊断的基于基于脑卒中的基于标记的基于基于诊断的基于基于脑卒中的基于标记的基于基于诊断,治疗和管理的基于诊断的基于基于诊断的基于诊断的基于诊断和/或内蛋白的脑卒中的标记的神经生物学表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号